Loading...

Our Goal

To accelerate translation of research from bench to bedside by providing services that support pre-clinical studies and regulatory submissions. These services are:
  • Confidential
  • Focused
  • Performed at no cost to the investigator

Available Services

  • Preclinical study planning & regulatory support
  • Pharmacology & toxicology services
  • Manufacturing of small molecules and non-biologics
  • Manufacturing of biologics
The SMARTT Program Workflow spans the following main phases: request services, NHLBI approval process, services implementation, translation and therapy.

Science Moving towArds Research Translation and Therapy

SMARTT Program Logo

Service Request Overview

  • Interested investigators submit an Eligibility Form
  • SMARTT Committee evaluates investigator eligibility for conformance to the NHLBI mission and to SMARTT capabilities
  • Eligible investigators submit a more detailed Request for Services Application (RSA)
  • RSAs are reviewed by a Scientific Review Board for merit and feasibility
  • Approved RSAs are assigned the appropriate program resources and the project is initiated.
  • After project completion, deliverables are provided to the investigator and service completion reports are submitted

SEARCH | ACCESSIBILITY | READERS & PLAYERS | SITE INDEX | OTHER SITES | PRIVACY STATEMENT | FOIA | CONTACT US | OIG

National Heart, Lung, and Blood Institute    National Institutes of Health    Department of Health and Human Services    USA.gov